Contacts
Media
media@incyte.com
Investors
ir@incyte.com
Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of January:
-
Goldman Sachs Annual Healthcare CEOs Unscripted Conference: A View from the Top on Thursday, January 4, 2024 at 9:30 am (EST)
-
42nd Annual J. P. Morgan Healthcare Conference on Monday, January 8, 2024 at 7:30 am (PST)
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay.
About Incyte
Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit Incyte.com and follow @Incyte.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231212377485/en/
Related news for (INCY)
- Pancreatic Cancer Treatments Poised for Major Advances in 2024
- Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)
- Incyte to Report Fourth Quarter and Year-End 2023 Financial Results
- Incyte Highlights Growth Opportunities and Provides Business Updates at the 42nd Annual J.P. Morgan Healthcare Conference